iShares Biotechnology ETF

Premium/discount is how far the market price trades above (+) or below (−) the fund's net asset value (reported in USD).

3-year risk statistics are not currently available for this fund.

Risk statistics are 3-year, month-end-based.

Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.

Fees & expenses

Category

Equity – SectorHealth Care

Asset class

Equity

Strategy

Passive

Themes

Biotechnology

Sector

Health Care

Region

US

Issuer

BlackRock Fund Advisors

Branding

iShares

Similar ETFs

Funds sharing the same category or exposures.

• XLVUS

  State Street® Health Care Select Sector SPDR® ETF

  Same category · Same sector · Same region

  $43.92B0.080%+11.63%
• GNOMUS

  Global X Genomics & Biotechnology ETF

  Same category · Same sector · biotechnology

  $105.69M0.500%+54.60%
• VGTUS

  Vanguard Information Technology Index Fund

  Same group · Same region

  $170.65B0.090%+34.36%
• XLKUS

  State Street® Technology Select Sector SPDR® ETF

  Same group · Same region

  $127.79B0.080%+36.81%
• XLFUS

  State Street® Financial Select Sector SPDR® ETF

  Same group · Same region

  $52.17B0.080%+1.34%
• XLEUS

  State Street® Energy Select Sector SPDR® ETF

  Same group · Same region

  $40.15B0.080%+41.51%

Frequently asked questions

What is IBB's expense ratio?

iShares Biotechnology ETF charges a net expense ratio of 0.440%.

How large is iShares Biotechnology ETF?

IBB holds $10.64B in assets under management.

What index does IBB track?

iShares Biotechnology ETF tracks NYSE Biotechnology as its primary benchmark.

When did IBB launch?

iShares Biotechnology ETF launched on February 5, 2001.

What currency does IBB trade in?

IBB trades in USD on Nasdaq - All Markets.

Fund information